LabGenius Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Employees
  • 61

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $43.9M

  • Investors
  • 33

LabGenius General Information

Description

Developer of next-generation protein-based therapeutics designed to address unmet needs like Inflammatory Bowel Disease. The company's therapeutics engineer protein drugs properties, such as protease stability and tissue penetration using their smart robotic platform designing, conducting, and critically learning from its experiments, enabling physicians to get access to protein therapeutics that are developed using robotic automation, synthetic biology, and advanced machine learning.

Contact Information

Website
www.labgeni.us
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • G04 Cocoa Studios, Biscuit Factory
  • 100 Drummond Road
  • London SE16 4DG
  • England, United Kingdom
+44 020
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Biotechnology
Drug Discovery
Vertical(s)
Artificial Intelligence & Machine Learning, Life Sciences
Corporate Office
  • G04 Cocoa Studios, Biscuit Factory
  • 100 Drummond Road
  • London SE16 4DG
  • England, United Kingdom
+44 020

LabGenius Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

LabGenius Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC (Series B) 24-Apr-2024 $43.9M Completed Generating Revenue
7. Grant 30-Nov-2022 Completed Generating Revenue
6. Later Stage VC (Series A) 29-Oct-2020 Completed Generating Revenue
5. Grant 01-Jul-2020 Completed Generating Revenue
4. Seed Round 24-Nov-2017 Completed Generating Revenue
3. Grant 01-Oct-2017 Completed Startup
2. Grant 09-Dec-2015 $75.7K Completed Startup
1. Grant 01-Jun-2015 $30.9K Completed Startup
To view LabGenius’s complete valuation and funding history, request access »

LabGenius Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series B2
Series B1
Series A2 Preferemce
Series A2 Preferemce
Series A1 Preference
Ordinary 173,900 $0.002351 $1 $1 1x $1 4.57%
Preference 228,322 $0.002351 $11.57 $11.57 1x $11.57 6%
To view LabGenius’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

LabGenius Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of next-generation protein-based therapeutics designed to address unmet needs like Inflammatory Bowel Disease.
Discovery Tools (Healthcare)
London, United Kingdom
61 As of 2024

Toronto, Canada
 

San Francisco, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

LabGenius Competitors (24)

One of LabGenius’s 24 competitors is ProteinQure, a Private Equity-Backed company based in Toronto, Canada.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
ProteinQure Private Equity-Backed Toronto, Canada
Atomwise Venture Capital-Backed San Francisco, CA
Molecular Assemblies Venture Capital-Backed San Diego, CA
Sygnature Discovery Private Equity-Backed Nottingham, United Kingdom
Ingenza Venture Capital-Backed Roslin, United Kingdom
You’re viewing 5 of 24 competitors. Get the full list »

LabGenius Patents

  • 11

    Total Documents Applications and Grants

  • Total Patents Families

  • 4

    Granted

  • 4

    Pending

  • Expiring in next 12 mo

LabGenius Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20220064634-A1 Methods and systems for protein engineering and production Pending 09-May-2019
EP-3966825-A1 Methods and systems for protein engineering and production Pending 09-May-2019
GB-201906566-D0 Methods and systems for protein engineering and production Inactive 09-May-2019
CA-3139359-A1 Methods and systems for protein engineering and production Pending 09-May-2019
JP-2022532707-A Methods and systems for protein engineering and protein production Pending 09-May-2019 G16B35/10
To view LabGenius’s complete patent history, request access »

LabGenius Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

LabGenius Investors (33)

Investor Name Investor Type Holding Investor Since Participating Rounds
Berggruen Holdings Family Office Minority
LG corporation Corporation Minority
M Ventures Corporate Venture Capital Minority
Octopus Ventures Venture Capital Minority
Providence Investment Company Venture Capital Minority
You’re viewing 5 of 33 investors. Get the full list »

Ready to get started?

Request a free trial

LabGenius FAQs

  • When was LabGenius founded?

    LabGenius was founded in 2012.

  • Where is LabGenius headquartered?

    LabGenius is headquartered in London, United Kingdom.

  • What is the size of LabGenius?

    LabGenius has 61 total employees.

  • What industry is LabGenius in?

    LabGenius’s primary industry is Discovery Tools (Healthcare).

  • Is LabGenius a private or public company?

    LabGenius is a Private company.

  • What is the current valuation of LabGenius?

    The current valuation of LabGenius is .

  • What is LabGenius’s current revenue?

    The current revenue for LabGenius is .

  • How much funding has LabGenius raised over time?

    LabGenius has raised $79.3M.

  • Who are LabGenius’s investors?

    Berggruen Holdings, LG corporation, M Ventures, Octopus Ventures, and Providence Investment Company are 5 of 33 investors who have invested in LabGenius.

  • Who are LabGenius’s competitors?

    ProteinQure, Atomwise, Molecular Assemblies, Sygnature Discovery, and Ingenza are some of the 24 competitors of LabGenius.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »